Human leukocyte antigen supertype matching after myeloablative hematopoietic cell transplantation with 7/8 matched unrelated donor allografts: a report from the Center for International Blood and Marrow Transplant Research.

PubWeight™: 0.78‹?›

🔗 View Article (PMID 27247320)

Published in Haematologica on May 31, 2016

Authors

Aleksandr Lazaryan1, Tao Wang2, Stephen R Spellman3, Hai-Lin Wang2, Joseph Pidala4, Taiga Nishihori4, Medhat Askar5, Richard Olsson6, Machteld Oudshoorn7, Hisham Abdel-Azim8, Agnes Yong9, Manish Gandhi10, Christopher Dandoy11, Bipin Savani12, Gregory Hale13, Kristin Page14, Menachem Bitan15, Ran Reshef16, William Drobyski17, Steven Ge Marsh18, Kirk Schultz19, Carlheinz R Müller20, Marcelo A Fernandez-Viña21, Michael R Verneris22, Mary M Horowitz2, Mukta Arora22, Daniel J Weisdorf22, Stephanie J Lee23

Author Affiliations

1: University of Minnesota Medical Center, Fairview, Minneapolis, MN, USA alazarya@umn.edu.
2: Center for International Blood and Marrow Transplant Research, Milwaukee, WI, USA.
3: Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA.
4: H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL, USA.
5: Baylor University Medical Center, Dallas, TX, USA.
6: Karolinska University Hospital, Centre for Allogeneic Stem Cell Transplantation, Stockholm, Sweden.
7: Leiden University Medical Centre, The Netherlands.
8: Children's Hospital of Los Angeles, CA, USA.
9: Royal Adelaide Hospital/SA Pathology, Australia.
10: Mayo Clinic, Rochester, MN, USA.
11: Cincinnati Children's Hospital Medical Center, OH, USA.
12: Vanderbilt University Medical Center, Nashville, TN, USA.
13: All Children's Hospital, St. Petersburg, FL, USA.
14: Duke University Medical Center, Pediatric Blood and Marrow Transplant, Durham, NC, USA.
15: Tel-Aviv Sourasky Medical Center, Israel.
16: Columbia University Medical Center, New York, NY, USA.
17: Froedtert Memorial Lutheran Hospital, Milwaukee, MN, USA.
18: Anthony Nolan Research Institute & University College London Cancer Institute, Royal Free Campus, UK.
19: British Columbia's Children's Hospital, Vancouver, British Columbia, Canada.
20: Zentrales Knochenmarkspender-Register Deutschland, Ulm, Germany.
21: Stanford University Medical Center, CA, USA.
22: University of Minnesota Medical Center, Fairview, Minneapolis, MN, USA.
23: Fred Hutchinson Cancer Research Center, Seattle, WA, USA.

Articles cited by this

1994 Consensus Conference on Acute GVHD Grading. Bone Marrow Transplant (1995) 24.01

High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood (2007) 9.82

Peripheral-blood stem cells versus bone marrow from unrelated donors. N Engl J Med (2012) 6.30

Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med (1997) 6.12

Impact of HLA class I and class II high-resolution matching on outcomes of unrelated donor bone marrow transplantation: HLA-C mismatching is associated with a strong adverse effect on transplantation outcome. Blood (2004) 4.91

Nine major HLA class I supertypes account for the vast preponderance of HLA-A and -B polymorphism. Immunogenetics (1999) 4.88

Advantage of rare HLA supertype in HIV disease progression. Nat Med (2003) 4.08

HLA class I supertypes: a revised and updated classification. BMC Immunol (2008) 3.47

Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study. Lancet Oncol (2012) 2.68

The IPD and IMGT/HLA database: allele variant databases. Nucleic Acids Res (2014) 2.66

Allogeneic marrow stem-cell transplantation from human leukocyte antigen-identical siblings versus human leukocyte antigen-allelic-matched unrelated donors (10/10) in patients with standard-risk hematologic malignancy: a prospective study from the French Society of Bone Marrow Transplantation and Cell Therapy. J Clin Oncol (2006) 2.54

High-risk HLA allele mismatch combinations responsible for severe acute graft-versus-host disease and implication for its molecular mechanism. Blood (2007) 2.46

Definition of supertypes for HLA molecules using clustering of specificity matrices. Immunogenetics (2004) 2.39

Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry. Biol Blood Marrow Transplant (2008) 2.08

Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation. Blood (2014) 1.89

Specificity of T-cell alloreactivity. Nat Rev Immunol (2007) 1.88

Identifiying human MHC supertypes using bioinformatic methods. J Immunol (2004) 1.72

Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics (2011) 1.68

Creation of a double chimera after the transplantation of umbilical-cord blood from two partially matched unrelated donors. N Engl J Med (2001) 1.63

Outcomes after matched unrelated donor versus identical sibling hematopoietic cell transplantation in adults with acute myelogenous leukemia. Blood (2012) 1.57

In silico identification of supertypes for class II MHCs. J Immunol (2005) 1.52

Overlap in the repertoires of peptides bound in vivo by a group of related class I HLA-B allotypes. Curr Biol (1995) 1.31

Identifying HLA supertypes by learning distance functions. Bioinformatics (2007) 1.28

Mapping the landscape of host-pathogen coevolution: HLA class I binding and its relationship with evolutionary conservation in human and viral proteins. J Virol (2010) 1.17

Highly diverged MHC class I mismatches are acceptable for haematopoietic stem cell transplantation. Bone Marrow Transplant (2007) 1.12

Definition of MHC supertypes through clustering of MHC peptide-binding repertoires. Methods Mol Biol (2007) 1.09

HLA mismatching within or outside of cross-reactive groups (CREGs) is associated with similar outcomes after unrelated hematopoietic stem cell transplantation. Blood (2007) 1.00

Identification of peptide vaccine candidates for prostate cancer patients with HLA-A3 supertype alleles. Clin Cancer Res (2005) 0.96

The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol (2011) 0.93

Clustering HLA class I superfamilies using structural interaction patterns. PLoS One (2014) 0.90

Human leukocyte antigen class I supertypes and HIV-1 control in African Americans. J Virol (2009) 0.88

New peptide vaccine candidates for epithelial cancer patients with HLA-A3 supertype alleles. J Immunother (2007) 0.83

HLA Class I Supertype Associations With Clinical Outcome of Secondary Dengue Virus Infections in Ethnic Thais. J Infect Dis (2015) 0.81

Relation of HLA class I and II supertypes with spontaneous clearance of hepatitis C virus. Genes Immun (2013) 0.79

Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site. Eur J Immunol (2000) 0.78